OtherBasic Science (Animal or Phantoms)
18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models
Hua Yang, Silvia Jenni, Milena Colovic, Helen Merkens, Carlee Poleschuk, Isabel Rodrigo, Qing Miao, Bruce F Johnson, Michael J Rishel, Vesna Sossi, Jack M. Webster, François Bénard and Paul Schaffer
Journal of Nuclear Medicine October 2016, jnumed.116.180661; DOI: https://doi.org/10.2967/jnumed.116.180661
Hua Yang
1 TRIUMF, Canada;
Silvia Jenni
2 British Columbia Cancer Agency, Canada;
Milena Colovic
1 TRIUMF, Canada;
Helen Merkens
3 British Columabia Cancer Agency, Canada;
Carlee Poleschuk
1 TRIUMF, Canada;
Isabel Rodrigo
1 TRIUMF, Canada;
Qing Miao
1 TRIUMF, Canada;
Bruce F Johnson
4 GE Global Research, United States;
Michael J Rishel
4 GE Global Research, United States;
Vesna Sossi
5 University of British Columbia, Canada
Jack M. Webster
4 GE Global Research, United States;
François Bénard
2 British Columbia Cancer Agency, Canada;
Paul Schaffer
1 TRIUMF, Canada;

Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models
Hua Yang, Silvia Jenni, Milena Colovic, Helen Merkens, Carlee Poleschuk, Isabel Rodrigo, Qing Miao, Bruce F Johnson, Michael J Rishel, Vesna Sossi, Jack M. Webster, François Bénard, Paul Schaffer
Journal of Nuclear Medicine Oct 2016, jnumed.116.180661; DOI: 10.2967/jnumed.116.180661
18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models
Hua Yang, Silvia Jenni, Milena Colovic, Helen Merkens, Carlee Poleschuk, Isabel Rodrigo, Qing Miao, Bruce F Johnson, Michael J Rishel, Vesna Sossi, Jack M. Webster, François Bénard, Paul Schaffer
Journal of Nuclear Medicine Oct 2016, jnumed.116.180661; DOI: 10.2967/jnumed.116.180661
Jump to section
Related Articles
Cited By...
- Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-L-Glutamate as System Formula-Targeting Radiopharmaceuticals
- Comparative Evaluation of [18F]5-Fluoroaminosuberic Acid and (4S)-4-3-[18F]fluoropropyl)-L-Glutamate as System Formula-Targeting Radiopharmaceuticals
- Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
- The Characterization of 18F-hGTS13 for Molecular Imaging of xC- Transporter Activity with PET
- Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
- Assessment of Tumor Redox Status through (S)-4-(3-[18F]fluoropropyl)-L-Glutamic Acid PET Imaging of System xc- Activity